288 related articles for article (PubMed ID: 15963870)
1. Nebulized versus subcutaneous morphine for patients with cancer dyspnea: a preliminary study.
Bruera E; Sala R; Spruyt O; Palmer JL; Zhang T; Willey J
J Pain Symptom Manage; 2005 Jun; 29(6):613-8. PubMed ID: 15963870
[TBL] [Abstract][Full Text] [Related]
2. Can we really say that nebulized morphine works?
Lasheen W; Panneerselvam A; Davis MP
J Pain Symptom Manage; 2006 Aug; 32(2):101-2; author reply 102-3. PubMed ID: 16877173
[No Abstract] [Full Text] [Related]
3. Relief of incident dyspnea in palliative cancer patients: a pilot, randomized, controlled trial comparing nebulized hydromorphone, systemic hydromorphone, and nebulized saline.
Charles MA; Reymond L; Israel F
J Pain Symptom Manage; 2008 Jul; 36(1):29-38. PubMed ID: 18358689
[TBL] [Abstract][Full Text] [Related]
4. Nebulized morphine for relief of dyspnea due to chronic lung disease.
Brown SJ; Eichner SF; Jones JR
Ann Pharmacother; 2005 Jun; 39(6):1088-92. PubMed ID: 15840735
[TBL] [Abstract][Full Text] [Related]
5. [Efficacy of controlled-release oxycodone for dyspnea in cancer patients--three case series].
Shinjo T; Okada M
Gan To Kagaku Ryoho; 2006 Apr; 33(4):529-32. PubMed ID: 16612168
[TBL] [Abstract][Full Text] [Related]
6. Does nebulized morphine offer symptom relief to patients with disabling dyspnea during end-stage disease?
Eaton B; Hall J; MacDonald S
Can Fam Physician; 1999 Feb; 45():319-20. PubMed ID: 10065305
[No Abstract] [Full Text] [Related]
7. Nebulized opioids for the palliation of dyspnea in terminally ill patients.
Afolabi TM; Nahata MC; Pai V
Am J Health Syst Pharm; 2017 Jul; 74(14):1053-1061. PubMed ID: 28687551
[TBL] [Abstract][Full Text] [Related]
8. Randomized clinical trial of nebulized fentanyl citrate versus i.v. fentanyl citrate in children presenting to the emergency department with acute pain.
Miner JR; Kletti C; Herold M; Hubbard D; Biros MH
Acad Emerg Med; 2007 Oct; 14(10):895-8. PubMed ID: 17898251
[TBL] [Abstract][Full Text] [Related]
9. Midazolam as adjunct therapy to morphine in the alleviation of severe dyspnea perception in patients with advanced cancer.
Navigante AH; Cerchietti LC; Castro MA; Lutteral MA; Cabalar ME
J Pain Symptom Manage; 2006 Jan; 31(1):38-47. PubMed ID: 16442481
[TBL] [Abstract][Full Text] [Related]
10. Oral versus intravenous opioid dosing for the initial treatment of acute musculoskeletal pain in the emergency department.
Miner JR; Moore J; Gray RO; Skinner L; Biros MH
Acad Emerg Med; 2008 Dec; 15(12):1234-40. PubMed ID: 18945240
[TBL] [Abstract][Full Text] [Related]
11. Nebulized fentanyl versus intravenous morphine in children with suspected limb fractures in the emergency department: a randomized controlled trial.
Furyk JS; Grabowski WJ; Black LH
Emerg Med Australas; 2009 Jun; 21(3):203-9. PubMed ID: 19527280
[TBL] [Abstract][Full Text] [Related]
12. Morphine for dyspnea control in terminal cancer patients: is it appropriate in Taiwan?
Hu WY; Chiu TY; Cheng SY; Chen CY
J Pain Symptom Manage; 2004 Oct; 28(4):356-63. PubMed ID: 15471653
[TBL] [Abstract][Full Text] [Related]
13. Nebulized morphine for the relief of dyspnea.
Mabe SR; Connelly JF
Am J Health Syst Pharm; 1995 Jan; 52(2):146-8. PubMed ID: 12879541
[No Abstract] [Full Text] [Related]
14. Intrathecal treatment in cancer patients unresponsive to multiple trials of systemic opioids.
Mercadante S; Intravaia G; Villari P; Ferrera P; Riina S; David F; Mangione S
Clin J Pain; 2007; 23(9):793-8. PubMed ID: 18075407
[TBL] [Abstract][Full Text] [Related]
15. The INFUSE-Morphine study: use of recombinant human hyaluronidase (rHuPH20) to enhance the absorption of subcutaneously administered morphine in patients with advanced illness.
Thomas JR; Wallace MS; Yocum RC; Vaughn DE; Haller MF; Flament J
J Pain Symptom Manage; 2009 Nov; 38(5):663-72. PubMed ID: 19819665
[TBL] [Abstract][Full Text] [Related]
16. Nebulized morphine as a treatment for dyspnea in a child with cystic fibrosis.
Cohen SP; Dawson TC
Pediatrics; 2002 Sep; 110(3):e38. PubMed ID: 12205288
[TBL] [Abstract][Full Text] [Related]
17. Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases.
Gamborg H; Riis J; Christrup L; Krantz T
J Opioid Manag; 2013; 9(4):269-74. PubMed ID: 24353020
[TBL] [Abstract][Full Text] [Related]
18. Effect of nebulized morphine in cancer patients with dyspnea: a pilot study.
Tanaka K; Shima Y; Kakinuma R; Kubota K; Ohe Y; Hojo F; Matsumoto T; Ohmatsu H; Goto K; Nagai K; Nishiwaki Y
Jpn J Clin Oncol; 1999 Dec; 29(12):600-3. PubMed ID: 10721941
[TBL] [Abstract][Full Text] [Related]
19. The INFUSE-Morphine IIB study: use of recombinant human hyaluronidase (rHuPH20) to enhance the absorption of subcutaneous morphine in healthy volunteers.
Thomas JR; Yocum RC; Haller MF; Flament J
J Pain Symptom Manage; 2009 Nov; 38(5):673-82. PubMed ID: 19819667
[TBL] [Abstract][Full Text] [Related]
20. The analgesic efficacy and safety of intra-articular morphine and mepivicaine following temporomandibular joint arthroplasty.
Zuniga JR; Ibanez C; Kozacko M
J Oral Maxillofac Surg; 2007 Aug; 65(8):1477-85. PubMed ID: 17656271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
